263 related articles for article (PubMed ID: 10570948)
1. Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism.
Ruiz L; Miguel A; Díaz-Laviada I
FEBS Lett; 1999 Sep; 458(3):400-4. PubMed ID: 10570948
[TBL] [Abstract][Full Text] [Related]
2. Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.
Sánchez C; Galve-Roperh I; Canova C; Brachet P; Guzmán M
FEBS Lett; 1998 Sep; 436(1):6-10. PubMed ID: 9771884
[TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
McMahon LR
Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
[TBL] [Abstract][Full Text] [Related]
4. delta(9)-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells. Involvement of CB1 cannabinoid receptor and Raf-1.
Velasco L; Ruiz L; Sánchez MG; Díaz-Laviada I
Eur J Biochem; 2001 Feb; 268(3):531-5. PubMed ID: 11168391
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids enhance human B-cell growth at low nanomolar concentrations.
Derocq JM; Ségui M; Marchand J; Le Fur G; Casellas P
FEBS Lett; 1995 Aug; 369(2-3):177-82. PubMed ID: 7544292
[TBL] [Abstract][Full Text] [Related]
6. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC.
Araya KA; David Pessoa Mahana C; González LG
Eur J Pharmacol; 2007 Oct; 572(1):32-9. PubMed ID: 17644088
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
[TBL] [Abstract][Full Text] [Related]
8. Internalization and recycling of the CB1 cannabinoid receptor.
Hsieh C; Brown S; Derleth C; Mackie K
J Neurochem; 1999 Aug; 73(2):493-501. PubMed ID: 10428044
[TBL] [Abstract][Full Text] [Related]
9. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
[TBL] [Abstract][Full Text] [Related]
11. Metabolic stimulation of mouse spleen lymphocytes by low doses of delta9-tetrahydrocannabinol.
Sánchez C; Velasco G; Guzmán M
Life Sci; 1997; 60(19):1709-17. PubMed ID: 9129126
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.
Tanda G; Pontieri FE; Di Chiara G
Science; 1997 Jun; 276(5321):2048-50. PubMed ID: 9197269
[TBL] [Abstract][Full Text] [Related]
13. R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism.
Ramer R; Brune K; Pahl A; Hinz B
Biochem Biophys Res Commun; 2001 Sep; 286(5):1144-52. PubMed ID: 11527419
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
Sim LJ; Hampson RE; Deadwyler SA; Childers SR
J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
Sim-Selley LJ; Martin BR
J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
[TBL] [Abstract][Full Text] [Related]
16. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
[TBL] [Abstract][Full Text] [Related]
17. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.
Lauckner JE; Hille B; Mackie K
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19144-9. PubMed ID: 16365309
[TBL] [Abstract][Full Text] [Related]
18. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme.
Blázquez C; Sánchez C; Daza A; Galve-Roperh I; Guzmán M
J Neurochem; 1999 Apr; 72(4):1759-68. PubMed ID: 10098887
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
[TBL] [Abstract][Full Text] [Related]
20. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].
Shivachar AC; Martin BR; Ellis EF
Biochem Pharmacol; 1996 Mar; 51(5):669-76. PubMed ID: 8615904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
